Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 5271395, 7 pages
https://doi.org/10.1155/2017/5271395
Research Article

The Association of Serum Levels of Brain-Derived Neurotrophic Factor with the Occurrence of and Recovery from Delirium in Older Medical Inpatients

1Pathology Department, Sligo University Hospital Sligo, Sligo, Ireland
2School of Biological Science, Cork Institute of Technology, Cork, Ireland
3Sligo Mental Health Services, Clarion Rd, Sligo, Ireland
4Cognitive Impairment Research Group (CIRG), Graduate Entry Medical School, University of Limerick, Limerick, Ireland
5Sligo Medical Academy, NUI Galway and Sligo Mental Health Services, Clarion Rd, Sligo, Ireland
6Research and Academic Institute of Athens, Athens, Greece

Correspondence should be addressed to Dimitrios Adamis; moc.oohay@simadaamid

Received 24 October 2016; Accepted 18 January 2017; Published 9 February 2017

Academic Editor: Anastasia Kotanidou

Copyright © 2017 John Williams et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. APA, Diagnostic and Statistical Manual of Mental Disorders DSM- 5, American Psychiatric Association, Washington, DC, USA, 5th edition, 2013.
  2. D. Adamis, D. Meagher, A. Treloar et al., “Phenomenological and biological correlates of improved cognitive function in hospitalized elderly medical inpatients,” Archives of Gerontology and Geriatrics, vol. 59, no. 3, pp. 593–598, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. A. M. J. MacLullich, A. Beaglehole, R. J. Hall, and D. J. Meagher, “Delirium and long-term cognitive impairment,” International Review of Psychiatry, vol. 21, no. 1, pp. 30–42, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Adamis, “Cytokines in the elderly,” in Cytokines, V. R. Preedy and R. Hunter, Eds., pp. 79–92, Taylor & Francis, 2011. View at Google Scholar
  5. D. Adamis, M. Lunn, F. C. Martin et al., “Cytokines and IGF-I in delirious and non-delirious acutely ill older medical inpatients,” Age and Ageing, vol. 38, no. 3, pp. 326–332, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Barde, “Biological roles of neurotrophins,” in Neurotrophic Factors, P. Aebischer and F. Hefti, Eds., vol. 134 of Handbook of Experimental Pharmacology, pp. 1–31, Springer, Berlin, Germany, 1999. View at Publisher · View at Google Scholar
  7. S. Linnarsson, C. A. Willson, and P. Ernfors, “Cell death in regenerating populations of neurons in BDNF mutant mice,” Molecular Brain Research, vol. 75, no. 1, pp. 61–69, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Tessarollo, “Pleiotropic functions of neurotrophins in development,” Cytokine & Growth Factor Reviews, vol. 9, no. 2, pp. 125–137, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Gillardon, C. Eschenfelde, R. A. Rush, and M. Zimmerman, “Increase in neuronal jun immunoreactivity and epidermal ngf levels following uv exposure of rat skin,” NeuroReport, vol. 6, no. 9, pp. 1322–1324, 1995. View at Publisher · View at Google Scholar · View at Scopus
  10. J. A. Vega, O. García-Suárez, J. Hannestad, M. Pérez-Pérez, and A. Germanà, “Neurotrophins and the immune system,” Journal of Anatomy, vol. 203, no. 1, pp. 1–19, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Hori, R. Yoshimura, Y. Yamada et al., “Effects of olanzapine on plasma levels of catecholamine metabolites, cytokines, and brain-derived neurotrophic factor in schizophrenic patients,” International Clinical Psychopharmacology, vol. 22, no. 1, pp. 21–27, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Yoshimura, M. Mitoma, A. Sugita et al., “Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 31, no. 5, pp. 1034–1037, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Laske, E. Stransky, T. Leyhe et al., “Decreased brain-derived neurotrophic factor (BDNF)- and ß-thromboglobulin (β-TG)- blood levels in Alzheimer's disease,” Thrombosis and Haemostasis, vol. 96, no. 1, pp. 102–103, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Ciammola, J. Sassone, M. Cannella et al., “Low brain-derived neurotrophic factor (BDNF) levels in serum of Huntington's disease patients,” American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, vol. 144, no. 4, pp. 574–577, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. M.-C. Huang, C.-H. Chen, H.-C. Liu, C.-C. Chen, C.-C. Ho, and S.-J. Leu, “Differential patterns of serum brain-derived neurotrophic factor levels in alcoholic patients with and without delirium tremens during acute withdrawal,” Alcoholism: Clinical and Experimental Research, vol. 35, no. 1, pp. 126–131, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Grandi, C. D. Tomasi, K. Fernandes et al., “Brain-derived neurotrophic factor and neuron-specific enolase, but not S100β, levels are associated to the occurrence of delirium in intensive care unit patients,” Journal of Critical Care, vol. 26, no. 2, pp. 133–137, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Brum, L. Stertz, E. Borba, D. Rumi, F. Kapczinski, and A. Camozzato, “Association of serum brain-derived neurotrophic factor (BDNF) and tumor necrosis factor-alpha (TNF-α) with diagnosis of delirium in oncology inpatients,” Revista Brasileira de Psiquiatria, vol. 37, no. 3, pp. 197–202, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. C. D. Tomasi, F. Vuolo, J. Generoso et al., “Biomarkers of delirium in a low-risk community-acquired pneumonia-induced sepsis,” Molecular Neurobiology, pp. 1–5, 2016. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Ritter, A. S. Miranda, V. R. Giombelli et al., “Brain-derived neurotrophic factor plasma levels are associated with mortality in critically ill patients even in the absence of brain injury,” Critical Care, vol. 16, article R234, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Meagher, “More attention, less confusion: time to lessen the burden of delirium,” International Review of Psychiatry, vol. 21, no. 1, pp. 1–3, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. Z. S. Nasreddine, N. A. Phillips, V. Bédirian et al., “The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment,” Journal of the American Geriatrics Society, vol. 53, no. 4, pp. 695–699, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. P. T. Trzepacz, D. Mittal, R. Torres, K. Kanary, J. Norton, and N. Jimerson, “Validation of the delirium rating scale-revised-98: comparison with the delirium rating scale and the cognitive test for delirium,” Journal of Neuropsychiatry and Clinical Neurosciences, vol. 13, no. 2, pp. 229–242, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Adamis, A. Devaney, E. Shanahan, G. McCarthy, and D. Meagher, “Defining ‘recovery’ for delirium research: a systematic review,” Age and Ageing, vol. 44, no. 2, pp. 318–321, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. W. A. Knaus, E. A. Draper, D. P. Wagner, and J. E. Zimmerman, “APACHE II: a severity of disease classification system,” Critical Care Medicine, vol. 13, no. 10, pp. 818–829, 1985. View at Publisher · View at Google Scholar · View at Scopus
  25. A. F. Jorm, “A short form of the informant questionnaire on cognitive decline in the elderly (IQCODE): development and cross-validation,” Psychological Medicine, vol. 24, no. 1, pp. 145–153, 1994. View at Publisher · View at Google Scholar · View at Scopus
  26. D. Adamis, F. C. Martin, A. Treloar, and A. J. D. Macdonald, “Capacity, consent, and selection bias in a study of delirium,” Journal of Medical Ethics, vol. 31, no. 3, pp. 137–143, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. D. Adamis, “Statistical methods for analysing longitudinal data in delirium studies,” International Review of Psychiatry, vol. 21, no. 1, pp. 74–85, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Ahmed, B. Leurent, and E. L. Sampson, “Risk factors for incident delirium among older people in acute hospital medical units: a systematic review and meta-analysis,” Age and Ageing, vol. 43, no. 3, pp. 326–333, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Cerejeira, H. Firmino, A. Vaz-Serra, and E. B. Mukaetova-Ladinska, “The neuroinflammatory hypothesis of delirium,” Acta Neuropathologica, vol. 119, no. 6, pp. 737–754, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Y. Cavus, N. Dilbaz, A. E. Darcin, F. Eren, H. Kaya, and O. Kaya, “Alterations in serum BDNF levels in early alcohol withdrawal and comparison with healthy controls,” Bulletin of Clinical Psychopharmacology, vol. 22, no. 3, pp. 210–215, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. D. Adamis, B. C. Van Munster, and A. J. D. Macdonald, “The genetics of deliria,” International Review of Psychiatry, vol. 21, no. 1, pp. 20–29, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Ikenouchi-Sugita, R. Yoshimura, N. Ueda, Y. Kodama, W. Umene-Nakano, and J. Nakamura, “Continuous decrease in serum brain-derived neurotrophic factor (BDNF) levels in a neuropsychiatric syndrome of systemic lupus erythematosus patient with organic brain changes,” Neuropsychiatric Disease and Treatment, vol. 4, no. 6, pp. 1277–1281, 2008. View at Google Scholar · View at Scopus
  33. A. Chiaretti, M. Piastra, G. Polidori et al., “Correlation between neurotrophic factor expression and outcome of children with severe traumatic brain injury,” Intensive Care Medicine, vol. 29, no. 8, pp. 1329–1338, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. D. Adamis, A. Treloar, F. C. Martin, N. Gregson, G. Hamilton, and A. J. D. Macdonald, “APOE and cytokines as biological markers for recovery of prevalent delirium in elderly medical inpatients,” International Journal of Geriatric Psychiatry, vol. 22, no. 7, pp. 688–694, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. D. Adamis and D. Meagher, “Insulin-like growth factor I and the pathogenesis of delirium: a review of current evidence,” Journal of Aging Research, vol. 2011, Article ID 951403, 11 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. W. Pan, W. A. Banks, M. B. Fasold, J. Bluth, and A. J. Kastin, “Transport of brain-derived neurotrophic factor across the blood-brain barrier,” Neuropharmacology, vol. 37, no. 12, pp. 1553–1561, 1998. View at Publisher · View at Google Scholar · View at Scopus
  37. F. Karege, M. Schwald, and M. Cisse, “Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets,” Neuroscience Letters, vol. 328, no. 3, pp. 261–264, 2002. View at Publisher · View at Google Scholar · View at Scopus